APDN logo

Applied DNA Sciences (APDN) Company Overview

Profile

Full Name:

Applied DNA Sciences, Inc.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

July 15, 2003

Indexes:

Not included

Website:

http://www.adnas.com

Description:

Applied DNA Sciences (APDN) is a biotechnology company that focuses on DNA-based security and authentication solutions. They provide innovative technologies to protect products and brands from counterfeiting and fraud, using DNA markers to verify authenticity in various industries, including textiles, pharmaceuticals, and consumer goods.

Key Details

Price

$0.16

Market Cap

$8.80 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$3.43 M(-74.33% YoY)

Annual EPS

-$1.82(+88.03% YoY)

PE Ratio

-

Annual ROE

-101.04%

Annual Debt To Equity

0.00

Beta

1.38

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Dec 17, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 25, 2024

Analyst ratings

Recent major analysts updates

Jun 10, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Feb 9, 24 HC Wainwright & Co.
Buy
Dec 8, 23 HC Wainwright & Co.
Buy
Aug 24, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy
Jul 14, 23 HC Wainwright & Co.
Buy
May 12, 23 HC Wainwright & Co.
Buy
May 8, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy

Screeners with APDN included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks with high beta
Stocks below SMA 200
Stocks recommended to hold
Best performing stocks last 3 months
Healthcare sector
All stocks
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.16
APDN price is $0.16

Price All-time High

$168000.00
APDN price is currently -100.00% below its historical high of $168000.00

Price Analysts Target

-
APDN price consensus analysts' forecast is unknown

Price Most Recent Change

-3.98%
APDN price was down -3.98% on Feb 22, 2025

Price YTD Change

-23.14%
APDN price is down -23.14% since January 1st

Price 3-Year Change

-99.72%
APDN price is down -99.72% over the past 3 years

Market cap

Market Cap

$8.80 M
APDN market capitalization is $8.80 million

Market Cap 3-Year Change

-58.62%
APDN market capitalization is down -58.62% over the past 3 years

Market Cap All-time High

$189.81 M
APDN market capitalization is currently -95.37% below its historical high of $189.81 million

Market Cap Sector Rank

16.59%
APDN market capitalization is higher than 16.59% of companies in Healthcare sector

Technical

Beta

1.38
APDN beta is 1.38

200-day SMA

$0.68
APDN price is currently -76.47% below its 200-day simple moving average

14-day RSI

39.71
APDN 14-day relative strength index is 39.71

30-day Relative Volume

2.11
APDN 30-day relative volume is 2.11

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$3.43 M
APDN annual revenue is $3.43 million

Annual Revenue Analysts Estimate

$5.20 M
APDN annual revenue is currently -34.07% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-74.33%
APDN annual revenue is down -74.33% year-on-year

Annual Revenue Sector Rank

20.54%
APDN annual revenue is higher than 20.54% of companies in Healthcare sector

Profit

Annual Gross Profit

$1.02 M
APDN annual gross profit is $1.02 million

Annual Gross Margin

29.63%
APDN annual gross profit margin is 29.63%

Annual Operating Profit

-$14.02 M
APDN annual operating income is -$14.02 million

Annual Operating Margin

-408.72%
APDN annual operating profit margin is -408.72%

Annual Net Income

-$6.99 M
APDN annual net profit is -$6.99 million

Annual Net Margin

-203.78%
APDN annual net profit margin is -203.78%

EPS

Annual EPS

-$1.82
APDN annual earnings per share is -$1.82

Annual EPS Analysts Estimate

-$1.22
APDN annual earnings per share is currently +49.18% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+88.03%
APDN annual earnings per share is up +88.03% year-on-year

Annual EPS Sector Rank

45.62%
APDN annual earnings per share is higher than 45.62% of companies in Healthcare sector

ROA & ROE

Annual ROA

-52.89%
APDN annual return on assets is -52.89%

Annual ROE

-101.04%
APDN annual return on equity is -101.04%

EBIT & EBITDA

Annual EBIT

-$14.02 M
APDN annual earnings before interest & taxes is -$14.02 million

Annual EBITDA

-$13.33 M
APDN annual EBITDA is -$13.33 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
APDN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
APDN price to earnings ratio is unknown

PB Ratio

PB Ratio

0.69
APDN price to book ratio is 0.69

PB Ratio Sector Rank

32.92%
APDN price to book ratio is higher than 32.92% of companies in Healthcare sector

PS Ratio

PS Ratio

2.35
APDN price to sales ratio is 2.35

PS Ratio Sector Rank

43.06%
APDN price to sales ratio is higher than 43.06% of companies in Healthcare sector

Enterprise value

Enterprise Value

$109.95 K
APDN enterprise value is $109.95 thousand

Enterprise Value Sector Rank

10.69%
APDN enterprise value is higher than 10.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.01
APDN EV/EBITDA is -0.01

EV/EBITDA Sector Rank

68.19%
APDN EV/EBITDA is higher than 68.19% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.36
APDN annual current ratio is 3.36

Annual Quick Ratio

3.17
APDN annual quick ratio is 3.17

Leverage

Annual Debt To Equity

0.00
APDN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
APDN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
APDN piotroski f-score is 3

Altman Z-Score

-35.34
APDN altman z-score is -35.34

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$12.79 M
APDN annual total assets is $12.79 million

Annual Non Current Assets

$4.74 M
APDN annual long term assets is $4.74 million

Annual Current Assets

$8.05 M
APDN annual total current assets is $8.05 million

Annual Cash & Cash Equivalents

$6.43 M
APDN annual cash & cash equivalents is $6.43 million

Equity

Annual Book Value

$9.14 M
APDN annual book value is $9.14 million

Annual Working Capital

$5.65 M
APDN annual working capital is $5.65 million

Liabilities

Annual Total Liabilities

$3.82 M
APDN annual total liabilities is $3.82 million

Annual Total Long Term Liabilities

$1.42 M
APDN annual total long term liabilities is $1.42 million

Annual Current Liabilities

$2.40 M
APDN annual total current liabilities is $2.40 million

Annual Accounts Payable

$1.17 M
APDN annual accounts payable is $1.17 million

Debt

Annual Total Debt

$739.10 K
APDN annual total debt is $739.10 thousand

Annual Total Debt 1-Year Change

-40.29%
APDN annual total debt is down -40.29% year-on-year

Annual Long Term Debt

$193.20 K
APDN annual long term debt is $193.20 thousand

Annual Short Term Debt

$545.90 K
APDN annual short term debt is $545.90 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$17.46 M
APDN annual total expenses is $17.46 million

Annual Operating Expenses

$15.04 M
APDN annual total operating expenses is $15.04 million

Annual Cost Of Goods Sold

$2.41 M
APDN annual cost of goods sold is $2.41 million

Annual SGA

$11.45 M
APDN annual SGA is $11.45 million

Annual D&A

$696.40 K
APDN annual depreciation & amortization is $696.40 thousand

Annual Interest Expense

-
APDN annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$13.71 M
APDN annual cash flow from operations is -$13.71 million

Annual CFO 1-Year Change

-120.52%
APDN annual cash flow from operations is down -120.52% year-on-year

Annual CFI

-$407.90 K
APDN annual cash flow from investing activities is -$407.90 thousand

Annual CFI 1-Year Change

+62.78%
APDN annual cash flow from investing activities is up +62.78% year-on-year

Annual CFF

$13.40 M
APDN annual cash flow from financing activities is $13.40 million

Annual CFF 1-Year Change

+100%
APDN annual cash flow from financing activities is up +100% year-on-year

Free CashFlow

Annual FCF

-$14.12 M
APDN annual free cash flow is -$14.12 million

Annual FCF 1-Year Change

-124.25%
APDN annual free cash flow is down -124.25% year-on-year

CAPEX

Annual CAPEX

$407.90 K
APDN annual capital expenditures is $407.90 thousand

Annual CAPEX 1-Year Change

+420.28%
APDN annual capital expenditures is up +420.28% year-on-year

Institutional Ownership

Similar stocks

CJJD logo
China Jo-Jo Drugstores (CJJD)
Turnstone Biologics (TSBX)
OMGA logo
Omega Therapeutics (OMGA)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
AEMD logo
Aethlon Medical (AEMD)
NURO logo
NeuroMetrix (NURO)
AIM logo
AIM ImmunoTech (AIM)
AIMD logo
Ainos (AIMD)
Neuphoria Therapeutics (NEUP)

FAQ

  • What is the ticker symbol for Applied DNA Sciences?
  • Does Applied DNA Sciences pay dividends?
  • What sector is Applied DNA Sciences in?
  • What industry is Applied DNA Sciences in?
  • What country is Applied DNA Sciences based in?
  • When did Applied DNA Sciences go public?
  • Is Applied DNA Sciences in the S&P 500?
  • Is Applied DNA Sciences in the NASDAQ 100?
  • Is Applied DNA Sciences in the Dow Jones?
  • When was Applied DNA Sciences's last earnings report?
  • When does Applied DNA Sciences report earnings?
  • Should I buy Applied DNA Sciences stock now?

What is the ticker symbol for Applied DNA Sciences?

The ticker symbol for Applied DNA Sciences is NASDAQ:APDN

Does Applied DNA Sciences pay dividends?

No, Applied DNA Sciences does not pay dividends

What sector is Applied DNA Sciences in?

Applied DNA Sciences is in the Healthcare sector

What industry is Applied DNA Sciences in?

Applied DNA Sciences is in the Diagnostics & Research industry

What country is Applied DNA Sciences based in?

Applied DNA Sciences is headquartered in United States

When did Applied DNA Sciences go public?

Applied DNA Sciences's initial public offering (IPO) was on July 15, 2003

Is Applied DNA Sciences in the S&P 500?

No, Applied DNA Sciences is not included in the S&P 500 index

Is Applied DNA Sciences in the NASDAQ 100?

No, Applied DNA Sciences is not included in the NASDAQ 100 index

Is Applied DNA Sciences in the Dow Jones?

No, Applied DNA Sciences is not included in the Dow Jones index

When was Applied DNA Sciences's last earnings report?

Applied DNA Sciences's most recent earnings report was on Feb 13, 2025

When does Applied DNA Sciences report earnings?

The next expected earnings date for Applied DNA Sciences is May 9, 2025

Should I buy Applied DNA Sciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions